Global Whole Exome Sequencing Market 2025-2029

Global Whole Exome Sequencing Market 2025-2029

The global whole exome sequencing market is forecasted to grow by USD 3742.8 mn during 2024-2029, accelerating at a CAGR of 21.1% during the forecast period. The report on the global whole exome sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements and precipitous decline in sequencing costs, expanding clinical utility and integration into standard diagnostic workflows, proliferation of large scale government and private precision medicine initiatives.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit -

https://www.technavio.com/report/report/whole-exome-sequencing-market-industry-analysis

Technavio's global whole exome sequencing market is segmented as below:

By Product

• Consumables
• Services
• Instruments

By Technology

• Sequencing by synthesis
• ION semiconductor sequencing
• Others

By Application

• Drug discovery and development
• Diagnostics
• Personalized medicine
• Prenatal and neonatal screening
• Others

Geography

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• The Netherlands
• Spain
• Russia
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of artificial intelligence and machine learning for accelerated variant interpretation as one of the prime reasons driving the global whole exome sequencing market growth during the next few years. Also, proliferation of whole exome sequencing in population health initiatives and mainstream clinical practice and ascendancy of long read sequencing technologies for enhanced exome characterization will lead to sizable demand in the market.

The report on the global whole exome sequencing market covers the following areas:

• Global whole exome sequencing market sizing
• Global whole exome sequencing market forecast
• Global whole exome sequencing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global whole exome sequencing market vendors that include Agilent Technologies Inc., Ambry Genetics, Azenta US Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., CD Genomics, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., GeneDx LLC, Illumina Inc., Laboratory Corp., Macrogen Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., PerkinElmer US LLC, ProPhase Labs, Inc., Psomagen Inc., QIAGEN N.V., Thermo Fisher Scientific Inc.. Also, the global whole exome sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth. Show more